Metformin and Complex I of the Electron Transport Chain
Metformin mildly and reversibly inhibits Complex I.
- Complex I: Target complex (NADH dehydrogenase)
- Partial: Inhibition type (dose-dependent, reversible)
- Low–High: Typical dose range (placeholder scale)
- Mitochondria: Site of action (inner membrane)
Mechanism of Complex I inhibition
Placeholder: metformin lowers electron transfer through Complex I.
Reduced ATP Production as a Cellular Energy Signal
Lower ATP output shifts the AMP:ATP energy charge ratio.
- Decreased: ATP output (placeholder magnitude)
- Increased: AMP:ATP ratio (energy stress signal)
- AMPK: Sensed by (energy checkpoint kinase)
- Minutes: Onset (placeholder timescale)
From electron flux to energy charge
Placeholder: reduced ATP synthesis raises AMP relative to ATP.
Compensatory AMPK Activation Restores Energy Balance
AMPK activation rebalances cellular metabolism after energy stress.
- AMPK: Kinase (AMP-activated protein kinase)
- Energy stress: Trigger (low ATP, high AMP)
- Multiple: Downstream targets (placeholder pathways)
- Adaptive: Effect (placeholder outcome)
AMPK as the compensatory switch
Placeholder: AMPK activation restores mitochondrial energy homeostasis.
Mild Mitochondrial Stress and the Hormesis Hypothesis
Mild, repeated stress may condition cells toward resilience.
- Hormesis: Hypothesis (mild stress, adaptive gain)
- Low-grade: Stress level (placeholder intensity)
- Adaptive: Response type (placeholder classification)
- Emerging: Evidence status (placeholder confidence)
Hormetic stress and adaptive response
Placeholder: mild mitochondrial stress may prime protective pathways.
Linking Mitochondrial Effects to Longevity Signaling
Mitochondrial stress signaling connects to longevity-associated pathways.
- Longevity: Linked pathway (placeholder network)
- AMPK axis: Proposed mediator (placeholder link)
- Hypothesis: Research stage (placeholder maturity)
- High: Translational interest (placeholder note)
From mitochondria to longevity signaling
Placeholder: mitochondrial signaling may extend toward longevity pathways.
Placeholder: the longevity link remains an active research hypothesis.